Skip to main content

Peer Review reports

From: Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma

Original Submission
23 Aug 2018 Submitted Original manuscript
30 Oct 2018 Reviewed Reviewer Report - K. Izuhara
16 Jan 2019 Reviewed Reviewer Report - Reviewer 2
8 Feb 2019 Reviewed Reviewer Report - Research Square
2 May 2019 Author responded Author comments - Mattis Gottlow
Resubmission - Version 2
2 May 2019 Submitted Manuscript version 2
13 May 2019 Reviewed Reviewer Report - K. Izuhara
20 May 2019 Reviewed Reviewer Report - Reviewer 2
20 May 2019 Reviewed Reviewer Report - Research Square
29 May 2019 Reviewed Reviewer Report - Reviewer 3
11 Jun 2019 Author responded Author comments - Mattis Gottlow
Resubmission - Version 3
11 Jun 2019 Submitted Manuscript version 3
Publishing
2 Jul 2019 Editorially accepted
17 Jul 2019 Article published 10.1186/s12890-019-0889-4

You can find further information about peer review here.

Back to article page